Arkolith/Insider Trading/IBRX/Form 4

Soon-Shiong Patrick

See remarks, Director, 10% OwnerImmunityBio, Inc. (IBRX) · full profile →Form 4 · filed Apr 2, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 31, 2026Conversion(C)4.6M$5.43$25.0M251.0M

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001189020-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML